Multi-drug DDS

Here we aim to improve the pharmacokinetic properties of anti-cancer drug delivery vehicles, by producing all-prodrug nanoparticles with defined compositions of active agents. The therapeutic nanoparticles are designed for hepatocellular carcinomas.